Go online to PeerView.com/DRD860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in atopic diseases discusses the relationship between type 2 inflammation and atopic diseases, as well as therapeutic options and strategies to improve patient quality of life. Upon completion of this activity, participants will be able to: Describe the relationship between type 2 inflammation and atopic diseases including asthma, atopic dermatitis, chronic rhinosinusitis with nasal polyps (CRS/NP), and eosinophilic esophagitis (EoE), as well as its relevance to novel biologic therapies, Assess the severity of allergic and inflammatory diseases according to evidence-based guidelines and impact on patient quality of life, Employ the latest clinical evidence with regard to efficacy and safety of novel and emerging biologic therapies to tailor treatment for patients with allergic and inflammatory diseases, Implement patient education and communication tactics in collaboration with other members of the healthcare team to improve patient adherence to medication regimens, self-management, and quality of life.
View all episodes
